London’s Air Street Capital has raised a large Fund III with eyes locked on backing early-stage European and North American AI companies.
Related Posts
Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic…
Your SEO strategy is optimized for a search engine that no longer exists.
Google I/O made it official: AI-generated answers are now front and center in search, and most brands have almost no…
How Amul is using AI dairy farming to put 36 million farmers first
AI dairy farming has found its most ambitious deployment yet – not in a Silicon Valley lab nor…